Talk:Patent
- Frequently the impression from popular discussions is that "one can't get software patents in Europe", the reality is quite different; there are many issued software patents in Europe.
Munich Convention forbids software patents.
The new material on "abuse of patents" suffers from serious POV defects. -- NetEsq 22:50 Jan 8, 2003 (UTC)
- Maybe there should be a separate page for "current controversies in patent law". Several commentators have noted that the US Patent office is overburdened, resulting in inappropriate issuance of patents. If we just need to write "commentators have noted...", then do that. This has mostly focused on patents related to genes and other biological discoveries. I brought up the patent extension issue specifically because of the announcement today that Bristol had settled an anti-trust suit for this activity. Perhaps it is history now, and should go in an appropriate heading/article:
- Unfortunately, that article is poorly written and does not explain what really was going on. Basically, under the Hatch-Waxman act, a brand name drug maker can register a pharmaceutical patent with the FDA that will preclude a generic drug maker from developing a product covered by the patent until the patent expires. What Bristol-Myers was accused of was fradulently claiming to the FDA that the scope of newly issuing patents did cover the brand name drug (thereby automatically triggering delays of the generic drug maker) when they did not. Therefore, this is not an abuse of an overburdened Patent Office but of the Food and Drug Administration in a regulatory regime specific to generic drugs. This content should go under a Hatch-Waxman Act or Generic drug article, not in patents and, if referring to this, the abuse of patents section is incorrect as written. Stephen C. Carlson 05:19 Jan 9, 2003 (UTC)
- Stephen, it sounds like you're very knowledgeable on this subject. Why don't you work on making the article better? - Zoe
- I tried to balance the example of patent extension with an example of patent violation (both are anecdotal, I admit). I believe that the justification for an institution is important in order to understand that institution. Consequently, failure of the institution to meet its expectations is also important. The "abuse" section is clearly of a different tone than the technical/lawyerish discription in the above sections. If we get away from the technical aspects, we open up the risk of getting into a debate. However, I don't think that it is complete without discussing how this institution actually behaves.
- This article is long enough as it is, so such examinations should probably go in a new article. Sound good? Can you recommend any names for such an article?